Motley Fool Money
Motley Fool Money
The Motley Fool
Customers for Life?
26 minutes Posted Jun 24, 2024 at 8:00 pm.
ResMed has had the market on sleep apnea cornered for a while, but new weight-loss drugs might be creeping in. We look at what could change based on recent studies and some other businesses that have established lifelong customers.
Bill Barker and Dylan Lewis discuss:- How weight-loss drugs like Eli Lilly’s Zepbound might be coming for ResMed and the sleep apnea market.- RXO take a bigger piece of the brokered transportation market, scooping up Coyote Logistics from UPS.- Target and Shopify linking up for a win-win partnership.
0:00
26:27
Download MP3
Show notes
ResMed has had the market on sleep apnea cornered for a while, but new weight-loss drugs might be creeping in. We look at what could change based on recent studies and some other businesses that have established lifelong customers.(00:21) Bill Barker and Dylan Lewis discuss:- How weight-loss drugs like Eli Lilly’s Zepbound might be coming for ResMed and the sleep apnea market.- RXO take a bigger piece of the brokered transportation market, scooping up Coyote Logistics from UPS.- Target and Shopify linking up for a win-win partnership.(13:02) Tim Beyers and Ricky Mulvey discuss the value of lifetime-customer relationships, why they’re huge for the likes of Apple, and Costco, and one lesser-known name that may have one too.Companies discussed: LLY, NVO, RMD, SPOT, AAPL, SNOWHost: Dylan LewisGuests: Tim Beyers, Tim Beyers, Ricky MulveyProducer: Ricky MulveyEngineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices